VR-SOAP:一种改善精神病年轻患者社交活动与参与度的模块化虚拟现实治疗——单盲多中心随机对照试验研究方案
该研究为单盲多中心随机对照试验方案,计划从荷兰精神卫生机构招募116名18-40岁精神分裂症谱系或其他精神病性障碍且存在社交功能问题的患者,随机分配至VR-SOAP组或主动VR对照(VRelax)组,两组均14次会话。主要结局为体验采样法测量的社交接触数量与质量、休闲活动及社会参与,在基线、治疗后及6个月随访时比较。
要点
- VR-SOAP为模块化虚拟现实治疗,含14次会话和5个模块,针对社交功能受损的多方面原因。
- 研究计划纳入116名18-40岁精神病性障碍且社交功能有问题的患者,随机分至VR-SOAP或VRelax组。
- 主要结局用体验采样法测量社交接触数量与质量、休闲活动和社会参与,随访至6个月。
核心结论
- 若VR-SOAP被证实有效,将为治疗师提供改善精神病年轻成人社交功能的工具。
- 由于治疗包含针对不同跨诊断因素的多个模块,该试验可能为改善一系列症状和障碍(如情绪、孤独症谱系和焦虑障碍)的社交功能的新治疗提供输入。
研究设计与样本
- 单盲多中心随机对照试验,计划从荷兰精神卫生机构招募116名18-40岁、DSM-5诊断为精神分裂症谱系或其他精神病性障碍且存在社交功能问题的患者。
- 参与者随机分配至实验条件(VR-SOAP)或主动VR对照条件(VRelax)。
- VR-SOAP由14次会话和5个模块组成,包括四个可选模块(1-4)和一个固定模块(5),针对社交功能受损的原因。
- VRelax由14次会话组成,包括心理教育、压力管理、放松技术以及在VR中探索放松环境。
- 在治疗前(基线)、治疗后和6个月随访时比较治疗效果。
主要发现
- 主要结局为社交接触的数量和质量、休闲活动和社会参与,采用体验采样法(ESM)测量。
- 次要结局包括精神病性症状、社交行为、社会认知、自尊、自我污名和偏执思维。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Young people with a psychotic disorder have the same social goals as their healthy peers, but their social networks are smaller, they participate less often in leisure activities and are less successful in work and education. Causes of these problems are multifaceted, but culminate in difficulties with interacting in daily life social situations. Current treatments have only moderate effects on social functioning and often target one specific domain. Virtual reality (VR) has the potential to improve the treatment of social interaction difficulties. We developed a modular VR treatment for social functioning and participation (VR-SOAP). In this study, the effect of this intervention will be investigated in a randomized controlled trial (RCT). METHODS: A total of 116 participants (age 18-40) with a DSM-5 diagnosis of schizophrenia spectrum or other psychotic disorder and problems with social functioning will be recruited from mental healthcare institutes in the Netherlands. Participants will be randomized to the experimental condition (VR-SOAP) or active VR control condition (VRelax). VR-SOAP consists of 14 sessions and 5 modules addressing causes of impaired social functioning: four optional modules (1-4) and one fixed module (5). Vrelax consists of 14 sessions that entail psychoeducation, stress management, relaxation techniques, and the exploration of relaxing environments in VR. Primary outcomes are quantity and quality of social contacts, leisure activities and social participation, measured with the experience sampling method (ESM). Secondary outcomes are psychiatric symptoms, social behaviour, social cognition, self-esteem, self-stigma and paranoid thoughts. Treatment effects will be compared at pre-treatment (baseline), post-treatment and at 6-month follow-up. DISCUSSION: If VR-SOAP proves to be effective, it provides therapists with a much-needed tool to improve social functioning of young adults with a psychotic disorder. Additionally, since the treatment consists of multiple modules targeting different transdiagnostic factors, this trial might provide input for new treatments to improve social functioning in a range of symptoms and disorders, e.g. mood, autism spectrum and anxiety disorders. TRIAL REGISTRATION: On the 10th of November 2021, this trial was registered prospectively in the Dutch Trial Register as NL9784 .
引用
- Meins IA, Muijsson-Bouwman DC, Nijman SA, et al. VR-SOAP, a modular virtual reality treatment for improving social activities and participation of young people with psychosis: a study protocol for a single-blind multi-centre randomized controlled trial. Trials. 2023. PMID: 37061694. doi:10.1186/s13063-023-07241-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。